Palantir Technologies Inc. Celularity Inc Transaction History

Palantir Technologies Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.43 - $4.31 $313,998 - $3.15 Million	-730,230 Reduced 86.01%	118,727 $274,000
Q2 2022 Aug 15, 2022	SELL	$2.81 - $12.91 $2.05 Million - $9.41 Million	-728,859 Reduced 46.19%	848,957 $2.89 Million
Q1 2022 May 16, 2022	SELL	$3.81 - $9.79 $1.09 Million - $2.79 Million	-285,424 Reduced 15.32%	1,577,816 $13.7 Million
Q4 2021 Feb 14, 2022	BUY	$4.64 - $7.46 $8.65 Million - $13.9 Million	1,863,240 New	1,863,240 $9.54 Million

23.6M

Ticker CELU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,424,000
Market Cap $319M
Description
Celularity Inc., a clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases. It operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. The company's lead therapeutic programs include CYCART-19, a placental-de...

Get notified when there are updates to the investment portfolio of Palantir Technologies Inc., based on Form 13F filings with the SEC.

Stay updated on Palantir Technologies Inc. with notifications on news.